ArticleTrials2022

Efficacy and safety of progressively reducing biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis in persistent remission: a study protocol for a non-inferiority randomized, controlled, single-blind trial.

Shangwen Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.